VAERS Reports UT8111AA

VAERS 2716791

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut8111aa

kritisch

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 22.11.2023
Impfdatum: 09.10.2023
Beginn: 18.11.2023
Tage bis Beginn: 40,0
Dosis: N/A
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Asthenia Basophil count decreased Basophil percentage decreased Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride increased Blood creatinine normal Blood glucose normal Blood potassium normal Blood sodium normal Blood urea decreased Brain natriuretic peptide increased

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on November 18, 2023 15:00 Verified By: MD on November 18, 2023 17:58 Encounter Info: Hospital, Inpatient, 11/18/23 - * Final Report * History of Present Illness/Subjective Chief complaint low oxygen HPI: Patient is a 68-year-old female patient well-known to me from my clinic history of severe COPD dependent on oxygen, anxiety, hypothyroidism, depression, hypertension, hyperlipidemia presented to emergency department via private vehicle complaining of shortness of breath that started about 2 weeks ago and progressively got worse. She states that she has sore throat cough and weakness. She states that her shortness of breath worsened significantly yesterday that prompted her to come to the emergency room today because he was getting even more worse. She is taking 1 and half liter of oxygen at home denies history of congestive heart failure. She is currently not taking any steroids. Upon presentation to the emergency room patient presented with a blood pressure of 204/111 oxygen saturation 88% temperature 36.3 BP remained elevated throughout the course of ER visit patient was initially given clonidine which was not effective and started on Cardene drip. Other laboratory data that was pertinent showed no white count normal kidney function normal liver enzymes BNP elevated 282 she does not have history of congestive heart failure recent echo few months ago showed normal EF. X-ray of the chest revealed pulmonary edema. Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI Physical Exam/Objective Vitals & Measurements most recent past 24 hours Hemodynamics Neurologic Patient Weight Patient Height None Reported General: Alert and oriented Eye: Pupils are equal, round and reactive to light HEENT: Normocephalic Neck: Supple, normal range of motion Oropharynx: mild oropharynx erythema, post nasal drip Respiratory: Lungs are clear to auscultation. decreased air entry bilaterally Cardiovascular: Normal rate, Regular rhythm. Gastrointestinal: Soft, Non-tender. Musculoskeletal: Normal range of motion, No focal tenderness Integumentary: Warm, Dry, No rash Neurologic: No focal weakness. Sensation intact. Normal mood and affect Assessment/Plan 1. COPD exacerbation J44.1 Patient is having COPD exacerbation. -Start COPD power plan. -Admit to ICU for close care. Patient is high risk for intubation. BIPAP as needed. 2. Hypertensive emergency I16.1 Evident from presenting blood pressure systolic blood pressure of 204. -Endorgan damage causing pulmonary edema due to congestive heart failure secondary to hypertensive emergency. -Start patient on Cardene drip with a goal of SBP 160 for next 24 hours. -Monitor in ICU setting check cardiac enzymes. -No need for echo since it was done just a few months ago. 3. Acute congestive heart failure I50.9 See problem #2 4. Pulmonary edema J81.1 Patient will be given Lasix 40 mg IV twice daily until resolution of pulmonary edema. 5. Acute on chronic respiratory failure J96.20 Noted. Continue with supplemental oxygen with oxygen saturation goal of 90 to 92%. 6. Hyperlipidemia E78.5 Resume home medications 7. Myalgia & Myositis M79.10 Resume home meds 8. Hypothyroidism E03.9 Noted. Latest TSH July of this year was normal. -Continue with home medications. 9. Depression F32.9 Continue with home meds. Due to a high probability of clinically significant, life threatening deterioration, the patient required my highest level of preparedness to intervene emergently and I personally spent 40 minutes of critical care time directly and personally managing the patient. This critical care time included obtaining a history, examining the patient, pulse oximetry, ordering and reviewing the studies, arranging urgent treatment with development of a management plan, evaluation of the patient?s response to treatment, frequent reassessment, and discussions with other clinicians. The critical care time was performed to assess and manage the high probability of imminent, life-threatening deterioration that could result in multi-organ failure. It was exclusive of separately billable procedures and treating other patients and teaching time. Please see the MDM section and the rest of this note for further information on patient assessment and treatment. Code Status None Recorded Chronic Problem List Anterior epistaxis Anxiety B12 deficiency Benign positional vertigo Chronic pain syndrome Depression Emphysema/COPD Fibromyalgia Hyperlipidemia Hypertriglyceridemia Hypothyroidism Lip ulcer Myalgia & Myositis Nasal septal deviation Nasal septal ulcer Olecranon bursitis, left elbow Olecranon bursitis, left elbow Osteoarthritis Osteopenia Peripheral neuropathy Polyp of labia and vulva Preop examination Sebaceous cyst Tobacco use Vaginal prolapse Vitamin D deficiency Procedure/Surgical History ?Colonoscopy (10/18/2023) ?Ventral hernia repair (03/11/2020) ?Colonoscopy (01/14/2020) ?Endoscopy (01/14/2020) ?Mammogram (03/18/2014) ?Left shoulder replacement (2010) ?Appendectomy ?Arthroscopy ?BACK SURGERY ?Gallbladder ?Hip replacement ?Hysterectomy ?Tonsillectomy Surgical History Internal 10/18/2023 Colonscpy Diagnostic/Screen MD 03/11/2020 Hernia Repair Abdominal Laparoscopic MD 01/14/2020 Colonscpy Diagnostic/Screen MD Medications Home Medications (26) Active albuterol 2.5 mg/3 mL (0.083%) inhalation solution See Instructions, PRN, 3 mL (1 vial) Neb Inhal every 4-6 hours albuterol-ipratropium inh soln 2.5 mg-0.5 mg/3 mL 3 mL, Neb Inhal, 4 Times Daily, TAKE 25 UNITS (INHALATION) 4 TIMES PER DAY Antivert 25 mg oral tablet 25 mg = 1 Tablet, PRN, Orally, TID atorvastatin 10 mg oral tablet 10 mg = 1 Tablet, Orally, At Bedtime cetirizine 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily Cymbalta 60 mg oral delayed release capsule 120 mg = 2 Capsule, Orally, Daily, do not crush or chew DME (Vendor) Oxygen See DME Order Details or printed requisition for more information., This is a print requisition order, cannot be ePrescribed. fluticasone 50 mCg/inh nasal spray 1 Spray, intraNASAL, BID folic acid 1 mg oral tablet 1 mg = 1 Tablet, Orally, Daily furosemide 40 mg oral tablet 40 mg = 1 Tablet, Orally, Daily Melatonin 5 mg oral capsule 5 mg = 1 Capsule, Orally, At Bedtime, Reported Neurontin 800 mg oral tablet 800 mg = 1 Tablet, Orally, 4 Times Daily olanzapine 5 mg oral tablet 5 mg = 1 Tablet, Orally, BID pantoprazole 40 mg oral delayed release tablet 1 Tablet, Orally, Daily Phenergan 25 mg oral tablet 25 mg = 1 Tablet, Orally, TID primidone 50 mg oral tablet 50 mg = 1 Tablet, Orally, BID propranolol 60 mg oral tablet 60 mg = 1 Tablet, Orally, TID Senna-Time 8.6 mg oral tablet 4 tablets, Orally, At Bedtime sertraline 25 mg oral tablet 25 mg = 1 Tablet, Orally, Daily Spiriva Respimat 2.5 mCg/inh inhalation aerosol (60 actuations) 2 Puff, Inhalation, Daily sucralfate 1 g oral tablet 1 GM = 1 Tablet, Orally, Before Meals and HS Synthroid 50 mCg (0.05 mg) oral tablet 50 mCg = 1 Tablet, Orally, Daily Trelegy Ellipta 100 mCg-62.5 mCg-25 mCg inhalation powder 1 Puff, Daily Voltaren Topical 1% topical gel 2 GM, Topical, BID Xanax 0.5 mg oral tablet 0.5 mg = 1 Tablet, Orally, BID Zanaflex 4 mg oral tablet 8 mg = 2 Tablet, Orally, TID Active Scheduled Inpatient Medications niCARdipine + Sodium Chloride 0.9% IV Continuous Titrate - See Comments 5 mg/hr One-Time Medications Given 11/17/23 00:00:00 TO 11/18/23 15:00:46 None Reported PRN Medications (0600 - 0559) from 11/17 - 11/18 None Reported Allergies NKA Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Former use, quit more than 90 days ago. Home/Environment married, 2 children Substance Abuse Denies Tobacco Tobacco Use: 10 or more cigarettes (1/2 pack or more)/day in last 30 days. Family History Cancer of colon: Father. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 7.1 k/cumm (11/18/23 11:17:00) RBC: 4.02 million/cumm (11/18/23 11:17:00) Hgb: 10.7 GM/dL Low (11/18/23 11:17:00) Hct: 33.3 % Low (11/18/23 11:17:00) MCV: 83 fL (11/18/23 11:17:00) MCH: 26.7 pg Low (11/18/23 11:17:00) MCHC: 32.2 GM/dL (11/18/23 11:17:00) RDW: 19.2 % High (11/18/23 11:17:00) Platelet: 221 k/cumm (11/18/23 11:17:00) MPV: 8.8 fL (11/18/23 11:17:00) Neutrophils %: 79 % (11/18/23 11:17:00) Lymphocytes %: 14 % (11/18/23 11:17:00) Monocytes %: 7 % (11/18/23 11:17:00) Eosinophils %: 1 % (11/18/23 11:17:00) Basophils %: 0 % (11/18/23 11:17:00) Absolute Neutrophil: 5.6 k/cumm (11/18/23 11:17:00) Absolute Lymphocyte: 1 k/cumm (11/18/23 11:17:00) Absolute Monocyte: 0.5 k/cumm (11/18/23 11:17:00) Absolute Eosinophil: 0 k/cumm (11/18/23 11:17:00) Absolute Basophil: 0 k/cumm (11/18/23 11:17:00) Chemistry: Sodium SerPl QN: 142 mmol/L (11/18/23 11:17:00) Potassium SerPl QN: 3.5 mmol/L (11/18/23 11:17:00) Chloride SerPl QN: 108 mmol/L (11/18/23 11:17:00) Carbon Dioxide SerPl QN: 31 mmol/L High (11/18/23 11:17:00) Anion Gap: 3 mmol/L (11/18/23 11:17:00) BUN SerPl QN: 6 mg/dL (11/18/23 11:17:00) Creatinine SerPl QN: 0.59 mg/dL Low (11/18/23 11:17:00) Estimated GFR (CKD-EPI, no race): >90 (11/18/23 11:17:00) Estimated CRCL (CG): 91 mL/min (11/18/23 11:17:00) Glucose SerPl QN: 99 mg/dL (11/18/23 11:17:00) Calcium Total SerPl QN: 8.9 mg/dL (11/18/23 11:17:00) Alkaline Phos SerPl QN: 88 Units/L (11/18/23 11:17:00) ALT SerPl QN: 9 Units/L (11/18/23 11:17:00) AST SerPl QN: 13 Units/L (11/18/23 11:17:00) Bilirubin Total SerPl QN: 0.3 mg/dL (11/18/23 11:17:00) Total Protein SerPl QN: 6.9 GM/dL (11/18/23 11:17:00) Albumin SerPl QN: 4.1 GM/dL (11/18/23 11:17:00) Troponin-I High Sensitivity: 8 ng/L (11/18/23 11:17:00) BNP Pl QN: 282 pg/mL High (11/18/23 11:17:00) Micro - Last 7 days Rapid Strep A Method: EIA (11/18/23 13:48:00) RapStrepA: Negative (11/18/23 13:48:00) Rapid Influenza Method: FIA (11/18/23 13:48:00) Rapid Influenza A: Negative (11/18/23 13:48:00) Rapid Influenza B: Negative (11/18/23 13:48:00) Coronavirus SARS Ag FIA: Not Detected (11/18/23 13:48:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/18/2023 11:28 - XR Chest PA or AP IMPRESSION:1. Chronic emphysema. Increased interstitial pulmonary markingsmainly seen in the bilateral lower lungs suggestive of pulmonaryedema. Stable cardiothoracic silhouette. No pneumothorax or largeeffusion.Thank you for consulting our team of subspecialty radiologists at Physicians Radiology. Please contact us with any questions. Signature Line Electronically Signed on 11/18/23 17:58 ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2715729

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

kritisch

Staat: WA
Alter: 67,0
Geschlecht: F
Eingang: 20.11.2023
Impfdatum: 19.10.2023
Beginn: 27.10.2023
Tage bis Beginn: 8,0
Dosis: UNK
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Sudden death

Symptomtext

Pt received vaccines on 10/19/23 and died suddenly on 10/27/23. PCP wanted to inform in case there was any correlation between the two.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sudden death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: No meddications
Allergien: -
Vorherige Impfungen: -

VAERS 2715698

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut8111aa

kritisch

Staat: -
Alter: 66,0
Geschlecht: F
Eingang: 20.11.2023
Impfdatum: 26.10.2023
Beginn: 16.11.2023
Tage bis Beginn: 21,0
Dosis: N/A
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time normal Acute respiratory failure Angiogram pulmonary abnormal Anion gap Aortic aneurysm Bacterial test negative Base excess decreased Basophil count increased Basophil percentage Bilirubin urine Blood bicarbonate normal Blood calcium normal Blood chloride normal Blood creatinine normal Blood gases Blood glucose increased Blood lactic acid increased Blood pH decreased

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on November 16, 2023 15:21 EST Verified By: MD on November 16, 2023 15:21 EST Encounter Info: Hospital, Inpatient, 11/16/23 - * Final Report * Chief Complaint Shortness of breath History of Present Illness/Subjective Patient is a 67 year old woman w/ severe COPD who presents to the ER w/ acute hypoxic and hypercarbic respiratory failure. EMS was called to patient's house due to report of respiratory distress. Upon arrival the patient was tripoding and struggling to breathe. She then became unresponsive and turned blue. HR dropped to the 30s. She was quickly intubated in the field and her color improved and her sats were in the 90s. She was brought to the ER for further evaluation. She was briefly paced in the field as well but has since had a normal HR w/out any pacer needs. Temp was low at 35.6. BP was normal. Labs were notable for a WBC count of 12K. Lactate was 4.4 and repeat was 2.5. Trop was 18 and went up to 300. EKG showed no acute ST changes. CTA was negative for PE but did show c/f bronchitis and possible RUL infiltrate. ABG showed a PCO2 of 71 and repeat was 63 after adjustment of the vent settings. She was sedated w/ propofol as she was biting the ET tube in the ER. She was given steroids and breathing treatments and admitted to the medicine service for further management. Review of Systems With the exception of that noted in the HPI all systems were reviewed and were negative. Physical Exam/Objective Vitals & Measurements most recent past 24 hours T: 35.6 ?C (Rectal) BP: 123/75 HR: 94 (Monitored) RR: 12 SpO2: 90% Oxygen Therapy: Ventilator FiO2: 0.30 Neurologic Glasgow Coma Score: 7 Constitutional: No acute distress, well-nourished Eyes: no scleral icterus ENMT: Moist oral mucosa, ETT in place Respiratory: coarse mechanical breath sounds bilaterally Cardiovascular: Regular rate and rhythm Gastrointestinal: non-distended Musculoskeletal: intact ROM Integumentary: no rashes Neurologic: sedated Assessment/Plan Patient is a 67 year old woman admitted w/ acute on chronic hypoxic and hypercarbic respiratory failure. 1. Acute on chronic respiratory failure with hypoxia and hypercapnia J96.21 -Intubated now -Repeat VBG now -See problem #3 2. Elevated troponin R77.8 -Likely demand ischemia -Serial troponin until downtrending -TTE to assess for new wall motion abnormalities -Telemetry 3. COPD exacerbation J44.1 -Solumedrol -Duonebs -Procal -Will treat w/ CTX and doxycycline for now given possible R sided infiltrate -Urine legionella and strep Ag 4. Coronary artery disease I25.10 -Continue statin and ASA 5. Diet-controlled diabetes mellitus E11.9 -CDA power plan in place -Carb controlled diet -Hypoglycemia protocol -Hold oral DM meds 6. Hyperlipidemia E78.2 -Continue statin 7. Hypertension I10 -Continue home antihypertensive regimen 8. Tobacco use Z72.0 -Encourage cessation -Nicotine patch PRN Due to a high probability of clinically significant, life threatening deterioration, the patient required my highest level of preparedness to intervene emergently and I personally spent 40 minutes of critical care time directly and personally managing the patient. This critical care time included obtaining a history, examining the patient, pulse oximetry, ordering and reviewing the studies, arranging urgent treatment with development of a management plan, evaluation of the patient?s response to treatment, frequent reassessment, and discussions with other clinicians. The critical care time was performed to assess and manage the high probability of imminent, life-threatening deterioration that could result in multi-organ failure. It was exclusive of separately billable procedures and treating other patients and teaching time. Please see the MDM section and the rest of this note for further information on patient assessment and treatment. Code Status Resuscitation Status - Ordered -- 11/16/23 15:11:00 EST, Full Code Chronic Problem List Abnormal LFTs Allergic rhinitis Cervix dysplasia COPD mixed type Coronary artery disease Diet-controlled diabetes mellitus Diverticulosis Elevated hemoglobin Encounter for long-term current use of medication Endometriosis of ovary Endometriosis of pelvic peritoneum Fatty liver History of GI bleed Hyperlipidemia Hypertension Menopausal syndrome Newly converted positive PPD test Nocturnal hypoxemia due to emphysema Osteopenia Parotid mass rt Pelvic congestion syndrome Screening for lung cancer Skin lesions Tobacco use Type 2 diabetes mellitus Procedure/Surgical History ?Colonoscopy (10/11/2023) ?Diabetic retinal eye exam (07/30/2021) ?Diabetic retinal eye exam (07/03/2021) ?Eye examination (03/03/2020) ?colonoscopy (12/08/2017) ?egd (12/07/2017) ?Mammogram (07/23/2014) ?exploratory lab (02/20/2006) ?Tubal ligation (1987) ?Tonsillectomy (1962) ?Cesarean Section ?heart cath with stents ?Oophorectomy ?T & A Surgical History Internal 10/11/2023 Colonscpy Diagnostic/Screen MD 12/08/2017 Colonscpy Diagnostic/Screen MD 12/07/2017 EGD Diagnostic MD 03/01/2017 Colonscpy Bx MD Medications Home Medications (17) Active albuterol 2.5 mg/3 mL (0.083%) inhalation solution 2.5 mg = 3 mL, PRN, Inhalation, Q6H Alcohol Swabs Not Applicable, Topical, Unscheduled, 1 per month to clean injection site. aspirin 81 mg oral tablet, chewable 81 mg = 1 Tablet, Orally, QAM atorvastatin 80 mg oral tablet 80 mg = 1 Tablet, Orally, At Bedtime Bevespi Aerosphere 9 mCg-4.8 mCg/inh inhalation aerosol 2 Puff, Inhalation, BID carvedilol 3.125 mg oral tablet 1 Tablet, Orally, BID cyanocobalamin 1000 mCg/mL injectable solution 1,000 mCg = 1 mL, Subcutaneous, Every Month DME (Vendor) Oxygen See DME Order Details or printed requisition for more information., This is a print requisition order, cannot be ePrescribed. DME (Vendor) Oxygen See DME Order Details or printed requisition for more information., This is a print requisition order, cannot be ePrescribed. DME (Vendor) Oxygen See DME Order Details or printed requisition for more information., This is a print requisition order, cannot be ePrescribed. lisinopril 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily Melatonin 6 mg, At Bedtime Nasonex 50 mCg/inh nasal spray 2 Spray, Nostrils, Both, Daily nitroGLYCerin 0.4 mg sublingual tablet 0.4 mg = 1 Tablet, PRN, Sublingually, Q5min pantoprazole 40 mg oral delayed release tablet 1 Tablet, Orally, QAM Syringes - Vitamin B12 3 mL with attached 21 gauge 1 inch needle, Injection, Every Month Vitamin D3 50,000 intl units oral capsule See Instructions, Take 1 capsule orally x 8 weeks, then every other week. Then go to OTC Vitamin D 800 IU daily Active Scheduled Inpatient Medications albuterol-ipratropium (albuterol-ipratropium inh soln 2.5 mg-0.5 mg/3 mL), Inhalation SOLN, 3 mL, Neb Inhal, Q6H, Start: 11/16/23 16:00:00 ceftRIAXone, Injection, 1 GM, IVPB, ONCE, Indication: Pneumonia - CAP, Start: 11/16/23 15:11:00 ceftRIAXone, Injection, 1 GM, IVPB, Q24H, Indication: Pneumonia - CAP, Start: 11/17/23 16:00:00 doxycycline, Capsule, 100 mg, Orally, BID, Indication: COPD Exacerbation, Start: 11/16/23 22:00:00 doxycycline, Capsule, 100 mg, Orally, BID, Indication: COPD Exacerbation, Start: 11/16/23 22:00:00 enoxaparin, Injection, 40 mg, Subcutaneous, Q24H, Start: 11/16/23 16:00:00 methylPREDNISolone (methylPREDNISolone sodium succinate), Injection, 40 mg, IV Push, Q12H, Start: 11/16/23 16:00:00 Propofol + Solution PREMIX IV Continuous Titrate - See Comments 40 mCg/kg/min 11/16/23 NORepinephrine PREMIX + Sodium Chloride 0.9% PREMIX IV Continuous Titrate - See Comments 6 mCg/min 11/16/23 Lactated Ringers 1,000 mL IV Continuous 100 mL/hr Dextrose 10% in Water 500 mL IV Continuous Per Core Diabetes App - See Comments Propofol + Solution PREMIX IV Continuous Titrate - See Comments One-Time Medications Given 11/15/23 00:00:00 TO 11/16/23 15:15:21 None Reported PRN Medications (0600 - 0559) from 11/15 - 11/16 glucagon, 1 mg, IM, Unscheduled, 0 Dose(s) glucose, Per Core Diabetes App , IV Push, Unscheduled, 0 Dose(s) insulin lispro, Per Core Diabetes App , Subcutaneous, Unscheduled, 0 Dose(s) propofol infusion bolus dose, 20 mg, Via Infusion Pump, Q15min, 0 Dose(s) Allergies codeine (Itching) morphine (Itching) Demerol. (critical) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Employment/School Retired, Work/School description: The patient is retired with no exposure to dust or fumes.. Home/Environment Lives with Family. Nutrition/Health Type of diet: The patient tries to limit her sodium and saturated fat intake.. Diet: Low sodium. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Alcoholism: Father. Epilepsy...: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 12 k/cumm High (11/16/23 11:09:00) RBC: 5.74 million/cumm High (11/16/23 11:09:00) Hgb: 16.3 GM/dL High (11/16/23 11:09:00) Hct: 49.6 % High (11/16/23 11:09:00) MCV: 86 fL (11/16/23 11:09:00) MCH: 28.4 pg (11/16/23 11:09:00) MCHC: 32.9 GM/dL (11/16/23 11:09:00) RDW: 15 % High (11/16/23 11:09:00) Platelet: 321 k/cumm (11/16/23 11:09:00) MPV: 9 fL (11/16/23 11:09:00) Neutrophils %: 46 % (11/16/23 11:09:00) Lymphocytes %: 33 % (11/16/23 11:09:00) Monocytes %: 6 % (11/16/23 11:09:00) Eosinophils %: 14 % (11/16/23 11:09:00) Basophils %: 1 % (11/16/23 11:09:00) Absolute Neutrophil: 5.5 k/cumm (11/16/23 11:09:00) Absolute Lymphocyte: 4 k/cumm High (11/16/23 11:09:00) Absolute Monocyte: 0.7 k/cumm (11/16/23 11:09:00) Absolute Eosinophil: 1.7 k/cumm High (11/16/23 11:09:00) Absolute Basophil: 0.2 k/cumm (11/16/23 11:09:00) Chemistry: Sodium SerPl QN: 140 mmol/L (11/16/23 11:09:00) Potassium SerPl QN: 5.2 mmol/L (11/16/23 11:09:00) Chloride SerPl QN: 103 mmol/L (11/16/23 11:09:00) Carbon Dioxide SerPl QN: 26 mmol/L (11/16/23 11:09:00) Anion Gap: 11 mmol/L (11/16/23 11:09:00) BUN SerPl QN: 13 mg/dL (11/16/23 11:09:00) Creatinine SerPl QN: 1.1 mg/dL (11/16/23 11:09:00) Estimated GFR (CKD-EPI, no race): 55 mL/min/1.73m2 Low (11/16/23 11:09:00) Estimated CRCL (CG): 46 mL/min Low (11/16/23 11:09:00) Glucose SerPl QN: 222 mg/dL High (11/16/23 11:09:00) Calcium Total SerPl QN: 9.1 mg/dL (11/16/23 11:09:00) Troponin-I High Sensitivity: 398 ng/L High (11/16/23 13:35:00) BNP Pl QN: 41 pg/mL (11/16/23 11:09:00) Lactate Venous Pl QN: 2.5 mmol/L High (11/16/23 13:35:00) Blood Gas Comment: 30% vent (11/16/23 12:23:00) pH Bld Arterial QN: 7.2 Low (11/16/23 12:23:00) PCO2 Bld Arterial QN: 63 mmHg Critical (11/16/23 12:23:00) PO2 Bld Arterial QN: 88 mmHg (11/16/23 12:23:00) Base Excess Bld Arterial: -5 mmol/L Low (11/16/23 12:23:00) Bicarb Bld Arterial Calc: 25 mmol/L (11/16/23 12:23:00) O2 Sat Bld Arterial Calc: 94 % Low (11/16/23 12:23:00) FIO2: 100% VENT (11/16/23 11:03:44) Patient Temperature: 37 DegC (11/16/23 12:23:00) Coagulation: PT: 10.9 seconds (11/16/23 11:09:00) INR: 0.95 (11/16/23 11:09:00) aPTT: 34.7 seconds (11/16/23 11:09:00) Urine Studies: Color: Light-Yellow (11/16/23 12:29:00) Clarity: Slightly Cloudy (11/16/23 12:29:00) Specific Gravity: 1.012 (11/16/23 12:29:00) pH: 7.5 (11/16/23 12:29:00) Protein: 300 Abnormal (11/16/23 12:29:00) Glucose: 70 Abnormal (11/16/23 12:29:00) Ketones: NEGATIVE (11/16/23 12:29:00) Bilirubin: NEGATIVE (11/16/23 12:29:00) Hgb Ur: Large 3+ Abnormal (11/16/23 12:29:00) Nitrite: NEGATIVE (11/16/23 12:29:00) Urobilinogen: Normal (11/16/23 12:29:00) Leukocyte Esterase Ur: NEGATIVE (11/16/23 12:29:00) WBC: 21-50 Abnormal (11/16/23 12:29:00) RBC: >100 Abnormal (11/16/23 12:29:00) Bacteria: NONE (11/16/23 12:29:00) Squamous Epithelial: Few (11/16/23 12:29:00) Hyaline Casts: 11-20 (11/16/23 12:29:00) All Other Labs: COVID 19 Specimen Source: Nasal (11/16/23 11:03:00) Coronavirus SARS-CoV2 Rapid: Not Detected (11/16/23 11:03:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/16/2023 11:20 - XR Chest PA or AP Portable IMPRESSION:1. The endotracheal tube terminates 5.5 cm above the carina.2. No acute cardiopulmonary findings. 11/16/2023 12:12 - XR Chest PA or AP Portable IMPRESSION:1. Endotracheal tube and nasogastric tube as expected.2. Possible right apical airspace opacity.Thank you for consulting our team of subspecialty radiologists at Radiology. 11/16/2023 12:51 - CTA Chest Pulm Embolism W/IV Contrast IMPRESSION:1. Negative for pulmonary embolus.2. Advanced emphysema with 6 mm noncalcified pulmonary nodule in theright middle lobe. Non-contrast chest CT at 6-12 months isrecommended. If the nodule is stable at time of repeat CT, thenfuture CT at 18-24 months (from today?s scan) recommended forhigh-risk patients.3. Bilateral upper lobe bronchial wall thickening, which can be seenin the setting of acute or chronic bronchitis.4. Saccular aneurysm arising from the left lateral margin of thedistal descending thoracic aorta, common new from CT abdomen andpelvis 12/8/2017.Results were communicated and receipt was documented in the Reporting System.Thank you for consulting our team of subspecialty radiologists at Radiology. Signature Line Electronically Signed on 11/16/23 15:21 EST ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2719026

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut8111aa

schwer

Staat: -
Alter: 85,0
Geschlecht: F
Eingang: 29.11.2023
Impfdatum: 01.11.2023
Beginn: 26.11.2023
Tage bis Beginn: 25,0
Dosis: N/A
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Alanine aminotransferase normal Anion gap Arteriosclerosis Aspartate aminotransferase increased Asthenia Bacterial test negative Base excess Basophil count decreased Basophil percentage decreased Bilirubin urine Bladder catheter temporary Bladder dilatation Bladder hypertrophy Blood albumin normal Blood alkaline phosphatase normal Blood bicarbonate decreased Blood bilirubin normal

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on November 26, 2023 00:45 Verified By: MD on November 26, 2023 00:45 Encounter Info: Hospital, Emergency, 11/25/23 - 11/26/23 * Final Report * Chief Complaint Weakness, chills History of Present Illness/Subjective This is an 85-year-old female with past medical history of stage III chronic kidney disease, insulin-dependent diabetes with peripheral neuropathy, hypothyroidism, hypertension, here yesterday following a fall. The patient states that she has been weak and malaise with shaking chills over the past few days, had an accidental fall yesterday in which she presented to the emergency department with a negative workup. She returns today with worsening shaking chills and malaise, workup to date is demonstrating findings suggestive of cystitis and pyelitis/pyelonephritis, with some gas in the urinary bladder, could not exclude emphysematous pyelonephritis. Urology was consulted and the recommendation per Dr was temporary bladder decompression with catheter with appropriate antibiotic coverage. No interventional or surgical recommendations, no indication for transfer. White blood cell count is normal with increased absolute neutrophil count. INR normal. Creatinine 1.47 with a BUN of 34, sodium 125, chloride 91, anion gap 15, serum bicarbonate 19, serum lactate elevated at 3.2, however, repeat was 1.1. Troponin 23, 35 on repeat, no chest pain. AST is 45 otherwise LFTs are normal. Urine showing pyuria, negative for bacteria, glucosuria noted, trace ketosis. COVID-19 negative, influenza negative. Blood glucose nearly 400. The patient has been persistently tachycardic with heart rate around 120s, respiratory rate in the high 20s to 30s although no hypoxia, no complaint of shortness of breath or cough, chest x-ray is clear. VBG 7.45 with a pCO2 of 30, respiratory compensation with hyperventilation in response to metabolic acidosis, pH normal. Review of Systems Complains of shaking chills, fever, bilateral flank pain, malaise, denies syncope, denies chest pain. Denies shortness of air or cough. Denies urinary frequency or dysuria. Remaining 10 point review of systems negative except as noted above. Physical Exam/Objective Vitals & Measurements most recent past 24 hours T: 38.7 ?C (Axillary) TMIN: 36.5 ?C (Oral) TMAX: 38.7 ?C (Axillary) BP: 138/70 HR: 120 (Monitored) HR: 119 (Peripheral) RR: 26 SpO2: 92% Oxygen Therapy: Room air WT: 74.90 kg (WFC) Hemodynamics Neurologic Patient Weight Current Daily Weight: 74.9 kg 11/25/23 Patient Height Current Height: 167.9 cm 11/25/23 Constitutional: No acute distress, well-nourished, nontoxic Eyes: PERRLA, normal conjunctiva ENMT: Oral mucosa very dry Neck: Supple, no JVD Respiratory: Lungs CTAB Cardiovascular: Regular rhythm, tachycardia Gastrointestinal: Soft, non-tender, non-distended, nontender. Musculoskeletal: No joint swelling, does have mild bilateral CVA tenderness to palpation Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan 1. Acute pyelonephritis N10 Given clinical and radiographic findings of bilateral pyelonephritis, critical illness with sepsis and possibly severe sepsis given acute kidney injury, and possible emphysematous pyelonephritis, will cover broadly per recommendations including empiric ESBL coverage as well as Pseudomonas coverage. Meropenem 1 g every 8 hours in addition to vancomycin. Follow urine cultures and procalcitonin to guide antibiotic de-escalation. 2. Sepsis A41.9 Present on admission, fever, tachycardia, tachypnea, elevated serum lactate. On repeat examination, capillary refill and tissue perfusion intact although there has been a 40 point drop in systolic blood pressure since the time the patient initially presented concerning for worsening sepsis. Will place in ICU for close hemodynamic monitoring and hemodynamic support if needed. Follow urine and blood cultures. Broad-spectrum antibiotic coverage. Follow procalcitonin levels as well. 3. Acute kidney injury N17.9 Likely prerenal, will check urine sodium and creatinine, fractional excretion of sodium, avoid nephrotoxic agents, renal dosing of medications. Hold ACE inhibitor, no IV contrast. 4. Acute hyponatremia E87.1 The patient has chronic hyponatremia, tends to run around 130. Blood sugar is 400, corrected sodium closer to 130 at this time. Will check thyroid function, correct hyperglycemia, gently hydrate and repeat in the morning 5. CKD stage 3 due to type 2 diabetes mellitus E11.22 Noted 6. Essential hypertension I10 Hold antihypertensives until hemodynamic stability is assured and then reimplement and titrate as needed 7. Depression with anxiety F41.8 Mood appropriate, does not appear to be on home medication for this. 8. Hypothyroidism E03.9 Check thyroid function and continue levothyroxine 9. Insulin dependent type 2 diabetes mellitus E11.9 Hold metformin, continue basal insulin at 10 units with sliding scale prandial coverage, A1c, Accu-Cheks 10. Vitamin B 12 deficiency E53.8 Continue supplementation Full code Heparin for DVT prophylaxis Code Status None Recorded Chronic Problem List Allergic rhinitis Bilateral hip pain Chronic kidney disease stage 3 (disorder) CKD stage 3 due to type 2 diabetes mellitus Depression with anxiety Diabetic peripheral neuropathy Double vision Encounter for long-term (current) use of medications Essential hypertension Heart murmur Hypercalcemia Hyperlipidemia Hyponatremia Hypothyroidism Insomnia Insulin dependent type 2 diabetes mellitus Iron deficiency Polyneuropathy due to type 2 diabetes mellitus (disorder) Vitamin B 12 deficiency Procedure/Surgical History ?Diabetic retinal eye exam (11/10/2022) ?Colonoscopy (01/01/2013) ?Bladder Surgery ?Cesarean delivery ?Hysterectomy Medications Home Medications (26) Active amLODIPine 10 mg oral tablet See Instructions, TAKE 1 TABLET EVERY DAY aspirin 81 mg oral tablet, chewable 81 mg, Orally, Daily Basaglar (insulin glargine) KwikPen 100 units/mL subcutaneous solution 10 Units, Subcutaneous, Daily, Use up to a total of 20 units daily, SEE INSTRUCTIONS FROM YOUR PROVIDER BD Single Use Swab 70% topical pad See Instructions, to cleanse area once to twice daily when testing blood sugars BD Ultra-Fine Nano (4mm x 32G) Pen Needle Use 1 per day, Subcutaneous, Daily, Use to inject Victoza once daily Blood Glucose Meter See Instructions, to test blood sugar once daily Blood Glucose Test Strips See Instructions, to test blood sugars once daily Clora Calcium , Orally, Daily Coenzyme Q10 100 mg oral capsule 100 mg = 1 Capsule, Orally, Daily DROPLET PEN NEEDLES 32GX4MM 32G X 4 MM See Instructions, USE TO INJECT VICTOZA SUBCUTANEOUSLY ONE TIME DAILY ferrous sulfate 325 mg (65 mg elemental iron) oral delayed release tablet 325 mg = 1 Tablet, Orally, TID, may take with food to minimize abdominal discomfort, avoid dairy products. FreeStyle Libre Glucose Reader Not Applicable, Other, Unscheduled FreeStyle Libre Sensors Use As Directed, Other, Unscheduled gabapentin 300 mg oral capsule 300 mg = 1 Capsule, Orally, Daily hydroCODONE-acetaminophen 5 mg-325 mg oral tablet 1 Tablet, PRN, Orally, Q6H, not to exceed 8 tablets/day Lancets See Instructions, to test blood sugars once daily levothyroxine 112 mCg (0.112 mg) oral tablet 112 mCg = 1 Tablet, Orally, Daily lisinopril 40 mg oral tablet See Instructions, TAKE 1 TABLET EVERY DAY lovastatin 40 mg oral tablet See Instructions, TAKE 1 TABLET EVERY DAY metFORMIN 500 mg oral tablet See Instructions, TAKE 2 TABLETS TWICE DAILY Misc Supplement , barefoot coral calcium complete with Vitamin D Potassium , Orally, Daily, Take one tablet (99 mg) by mouth daily. traZODONE 50 mg oral tablet See Instructions, TAKE 1 TABLET AT BEDTIME Trulicity Pen 0.75 mg/0.5 mL subcutaneous solution 0.75 mg, Subcutaneous, Every Week Tylenol Extra Strength 500 mg, Orally, BID venlafaxine 75 mg oral capsule, extended release See Instructions, TAKE 1 CAPSULE EVERY DAY Active Scheduled Inpatient Medications None Reported One-Time Medications Given 11/25/23 00:00:00 TO 11/26/23 00:45:43 acetaminophen, Tablet, 1,000 mg, Orally, ONCE, (1 DOSE 11/25/23 23:14:00) ceftRIAXone, Injection, 2 GM, IV Push, ONCE, (1 DOSE 11/25/23 21:00:00) ondansetron, Injection, 4 mg, IV Push, ONCE, (1 DOSE 11/25/23 19:49:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 11/25/23 21:48:00) PRN Medications (0600 - 0559) from 11/25 - 11/26 None Reported Allergies Mushrooms Wygesic (Unknown) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Employment/School Retired, Work/School description: IU ticket office. Keeps busy with handiwork (crochet).. Home/Environment Pt. lives with spouse, Home equipment: Walker/Cane, Partial upper denture. Nutrition/Health Type of diet: Pt. eats two to three meals daily. Caffeine intake amount: half caf coffee - 2 cups daily. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Diabetes mellitus type 1: Mother. Heart disease..: Mother. High blood pressure..: Mother. Stroke: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 9.7 k/cumm (11/25/23 19:28:00) RBC: 4.36 million/cumm (11/25/23 19:28:00) Hgb: 11.4 GM/dL Low (11/25/23 19:28:00) Hct: 35 % (11/25/23 19:28:00) MCV: 80 fL Low (11/25/23 19:28:00) MCH: 26.1 pg Low (11/25/23 19:28:00) MCHC: 32.5 GM/dL (11/25/23 19:28:00) RDW: 14.1 % (11/25/23 19:28:00) Platelet: 232 k/cumm (11/25/23 19:28:00) MPV: 8.1 fL (11/25/23 19:28:00) Neutrophils %: 91 % (11/25/23 19:28:00) Lymphocytes %: 5 % (11/25/23 19:28:00) Monocytes %: 3 % (11/25/23 19:28:00) Eosinophils %: 0 % (11/25/23 19:28:00) Basophils %: 0 % (11/25/23 19:28:00) Absolute Neutrophil: 8.8 k/cumm High (11/25/23 19:28:00) Absolute Lymphocyte: 0.5 k/cumm Low (11/25/23 19:28:00) Absolute Monocyte: 0.3 k/cumm (11/25/23 19:28:00) Absolute Eosinophil: 0 k/cumm (11/25/23 19:28:00) Absolute Basophil: 0 k/cumm (11/25/23 19:28:00) Chemistry: Sodium SerPl QN: 125 mmol/L Low (11/25/23 19:28:00) Potassium SerPl QN: 4.1 mmol/L (11/25/23 19:28:00) Chloride SerPl QN: 91 mmol/L Low (11/25/23 19:28:00) Carbon Dioxide SerPl QN: 19 mmol/L Low (11/25/23 19:28:00) Anion Gap: 15 mmol/L High (11/25/23 19:28:00) BUN SerPl QN: 34 mg/dL High (11/25/23 19:28:00) Creatinine SerPl QN: 1.47 mg/dL High (11/25/23 19:28:00) Estimated GFR (CKD-EPI, no race): 35 mL/min/1.73m2 Low (11/25/23 19:28:00) Estimated CRCL (CG): 29 mL/min Low (11/25/23 19:28:00) Glucose SerPl QN: 395 mg/dL High (11/25/23 19:28:00) Calcium Total SerPl QN: 9.3 mg/dL (11/25/23 19:28:00) Alkaline Phos SerPl QN: 84 Units/L (11/25/23 19:28:00) ALT SerPl QN: 26 Units/L (11/25/23 19:28:00) AST SerPl QN: 45 Units/L High (11/25/23 19:28:00) Bilirubin Total SerPl QN: 0.6 mg/dL (11/25/23 19:28:00) Total Protein SerPl QN: 7.5 GM/dL (11/25/23 19:28:00) Albumin SerPl QN: 4.1 GM/dL (11/25/23 19:28:00) Lipase SerPl QN: 41 Units/L (11/25/23 19:28:00) Troponin-I High Sensitivity: 35 ng/L High (11/25/23 21:46:00) Ketones SerPl QN: Negative (11/25/23 19:28:00) Lactate Venous Pl QN: 1.1 mmol/L (11/25/23 22:55:00) Blood Gas Comment: venous (11/25/23 19:27:00) pH Bld Venous QN: 7.45 (11/25/23 19:27:00) PCO2 Bld Venous QN: 30 mmHg Low (11/25/23 19:27:00) PO2 Bld Venous QN: 42 mmHg (11/25/23 19:27:00) Base Excess Bld Venous: -2 mmol/L (11/25/23 19:27:00) Bicarb Bld Venous Calc: 21 mmol/L Low (11/25/23 19:27:00) O2 Sat Bld Venous Calc: 80 % (11/25/23 19:27:00) Patient Temperature: 37 DegC (11/25/23 19:27:00) TSH 3rd Gen SerPl QN: 0.968 mcU/mL (11/25/23 20:48:00) Coagulation: PT: 11.8 seconds (11/25/23 19:28:00) INR: 1.04 (11/25/23 19:28:00) Urine Studies: Color: Yellow (11/25/23 20:58:00) Clarity: Slightly Cloudy (11/25/23 20:58:00) Specific Gravity: 1.014 (11/25/23 20:58:00) pH: 7 (11/25/23 20:58:00) Protein: 100 Abnormal (11/25/23 20:58:00) Glucose: 1000 Abnormal (11/25/23 20:58:00) Ketones: TRACE. Abnormal (11/25/23 20:58:00) Bilirubin: NEGATIVE (11/25/23 20:58:00) Hgb Ur: Mod 2+ Abnormal (11/25/23 20:58:00) Nitrite: NEGATIVE (11/25/23 20:58:00) Urobilinogen: Normal (11/25/23 20:58:00) Leukocyte Esterase Ur: Large500 Abnormal (11/25/23 20:58:00) WBC: 21-50 Abnormal (11/25/23 20:58:00) RBC: 21-50 Abnormal (11/25/23 20:58:00) Bacteria: NONE (11/25/23 20:58:00) Squamous Epithelial: Few (11/25/23 20:58:00) Mucous: PRESENT. (11/25/23 20:58:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (11/25/23 20:48:00) Coronavirus SARS-CoV2 Rapid: Not Detected (11/25/23 20:48:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (11/25/23 20:48:00) Rapid Influenza A PCR: Not Detected (11/25/23 20:48:00) Rapid Influenza B PCR: Not Detected (11/25/23 20:48:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/25/2023 21:48 - XR Chest PA or AP Portable IMPRESSION:1. No acute findings in the chest.Thank you for consulting our team of subspecialty radiologists at Physicians Radiology. Please contact us with any questions. 11/25/2023 21:51 - CT Head W/o IV Contrast IMPRESSION: 1. No acute CT abnormality of the head. No acute intracranialhemorrhage or hydrocephalus.2. Findings raising question for normal pressure hydrocephalus forwhich clinical correlation is recommended.-Thank you for consulting our team of subspecialty radiologists at Physicians Radiology. Please contact us with any questions. 11/25/2023 21:52 - CT Abd/Pelvis W/O IV Contrast IMPRESSION:1. Bladder wall appears somewhat thickened for degree of distention.Correlate for cystitis. There is nonspecific perinephric stranding.Ascending urinary tract infection is not excludable on imaging. Noevidence of ureteral stone or obstruction.2. Gas in the urinary bladder. This could be a normal finding ifthere has been recent catheterization or instrumentation. Otherwiseintraluminal gas can be sign of infection with gas producingorganisms or fistula.3. Colonic diverticulosis without evidence of acute diverticulitis.4. Atherosclerosis including coronary artery disease.Thank you for consulting our team of subspecialty radiologists at Physicians Radiology. Please contact us with any questions. 11/25/2023 21:57 - CT Cervical Spine W/o IV Contrast IMPRESSION: 1. No acute findings of the cervical spine.2. A 5 mm RIGHT upper lobe lung nodule. If patient has risk factorsfor lung cancer, consider 12 month follow-up chest CT withoutcontrast. If low risk no specific follow-up is needed. Thank you for consulting our team of subspecialty radiologists at Physicians Radiology. Please contact us with any questions. Signature Line Electronically Signed on 11/26/23 00:45 ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2716348

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

schwer

Staat: NV
Alter: -
Geschlecht: F
Eingang: 21.11.2023
Impfdatum: 21.11.2023
Beginn: 21.11.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Head injury Loss of consciousness

Symptomtext

Patient stated they have a headache. Continued to get vaccine. Patient waited after vaccines; no reactions occurred at that time. Left the store and when elsewhere and patient passed out and hit head.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2718641

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

mild

Staat: CA
Alter: 79,0
Geschlecht: F
Eingang: 28.11.2023
Impfdatum: 26.11.2023
Beginn: 26.11.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Nausea Pain

Symptomtext

Patient reports severe full body pain and nausea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nausea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2698882

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

mild

Staat: WA
Alter: 68,0
Geschlecht: M
Eingang: 19.10.2023
Impfdatum: 08.10.2023
Beginn: 09.10.2023
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Rash erythematous Rash pruritic

Symptomtext

itchy red dots all over body starting about 24 hours after the shot. Symptoms are improving but still having some today

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: diabetes
Vorgeschichte: diabeties
Andere Medikamente: unknown
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2691316

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut8111aa

mild

Staat: OR
Alter: 71,0
Geschlecht: F
Eingang: 05.10.2023
Impfdatum: 02.10.2023
Beginn: 02.10.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Fatigue Myalgia

Symptomtext

chills, fatigue, muscle ache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: penicillin,gabapentin
Vorherige Impfungen: -

VAERS 2685735

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

mild

Staat: WA
Alter: 76,0
Geschlecht: M
Eingang: 22.09.2023
Impfdatum: 10.09.2023
Beginn: 19.09.2023
Tage bis Beginn: 9,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site vesicles

Symptomtext

PATIENT NOTICED A BLISTER LOOKING AT THE INJECTION SITE OF HIS LEFT ARM, WHERE HE GOT RSV SHOT, ON SEPTEMBER 19TH (A WEEK FROM RECEIVING HIS SHOTS). HE CLAIMS THAT THIS BLISTER HAS BEEN POPPED AFTER HE NOTICED BUT DOES NOT FEEL ANY PAIN NOR SWELLING HAS SHOWN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site vesicles
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2728970

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

gering

Staat: WA
Alter: 81,0
Geschlecht: F
Eingang: 31.12.2023
Impfdatum: 05.10.2023
Beginn: 19.10.2023
Tage bis Beginn: 14,0
Dosis: UNK
Route/Site: - / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Aphasia Brain fog

Symptomtext

I could not put two syllables together to make any sense, although I knew what I wanted to say to my friends. It lasted at least ten minutes. I did not have any other adverse effect that I am aware of, although I think that there was lingering "brain fog". My husband drove me to primary care office where we were told to drive directly to hospital in next town because that would be faster than waiting for ambulance (agreed).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Aphasia
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: T12 burst fracture sustained on 09/06/2023
Vorgeschichte: none
Andere Medikamente: calcium supplement, Vitamin D3 (both "prescribed " by doctor)
Allergien: malarone (malaria med.)
Vorherige Impfungen: -

VAERS 2717765

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

gering

Staat: NV
Alter: 56,0
Geschlecht: M
Eingang: 25.11.2023
Impfdatum: 27.09.2023
Beginn: 27.09.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

On the consent form Pt put DOB wrong and age as 66 years old. Subsequently, Pt was given Fluzone High Dose as a vaccine. Pt did not experience any adverse reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2716884

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

gering

Staat: AZ
Alter: 55,0
Geschlecht: M
Eingang: 22.11.2023
Impfdatum: 03.10.2023
Beginn: 03.10.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age

Symptomtext

55 YEAR OLD PATIENT WAS GIVE A FLUZONE HD VACCINATION

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2708281

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

gering

Staat: CA
Alter: 35,0
Geschlecht: M
Eingang: 01.11.2023
Impfdatum: 01.11.2023
Beginn: 01.11.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age Product administration error

Symptomtext

Patient age verified but high dose vaccine given by mistake

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: -

VAERS 2692786

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

gering

Staat: CA
Alter: 78,0
Geschlecht: F
Eingang: 09.10.2023
Impfdatum: 06.10.2023
Beginn: 07.10.2023
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Erythema Hypersensitivity Peripheral swelling Skin warm

Symptomtext

PATIENT HAD AN ALLERGIC REACTION TO FLUZONE HD. HER ARM WAS HOT TO THE TOUCH, RED AND SWOLLEN. PATIENT WAS ADVISED TO TAKE IBUPROFEN AND CALL DOCTOR IF SWELLING DOES NOT RESOLVE WITH 3 TO 5 DAYS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2688288

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut8111aa

gering

Staat: AZ
Alter: 62,0
Geschlecht: F
Eingang: 28.09.2023
Impfdatum: 26.09.2023
Beginn: 28.09.2023
Tage bis Beginn: 2,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

Gave patient the high dose flu shot and she is not 65+ No adverse reactions

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Sertraline 50mg, triamcinolone 0.1% cream, estradiol 0.5mg tabs
Allergien: none
Vorherige Impfungen: -

VAERS 2687148

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

gering

Staat: WA
Alter: 62,0
Geschlecht: F
Eingang: 27.09.2023
Impfdatum: 26.09.2023
Beginn: 26.09.2023
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

We had a nurse here giving vaccines and despite us processing the rx for flublok he gave the patient fluzone HD by mistake. He mixed up her vaccine with her husband's vaccine (who was over 65). He caught his mistake after and husband received correct vaccine. No adverse events have been reported by patient and she was notified of the mistake.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: none
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 2682801

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8111AA

gering

Staat: CA
Alter: 62,0
Geschlecht: M
Eingang: 16.09.2023
Impfdatum: 15.09.2023
Beginn: 15.09.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age

Symptomtext

Patient was given fluzone HD instead of fluzone quadrivalent, patient was notified of this error

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: there were no medical test or laboratory results conducted
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -